John O’Brien Promoted To HHS Senior Adviser For Drug Pricing Reform

By Rachel Cohrs / December 6, 2018 at 1:08 PM

HHS Secretary Alex Azar announced Thursday (Nov. 6) that John O’Brien is being promoted to senior adviser for drug pricing reform, a post formerly held by Dan Best, who died on Nov. 1.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.